🇬🇧 Antibiotic-resistant sepsis still claiming newborn lives in Africa: Penta leads new scientific collaboration to improve treatment and reduce mortality
27 Jul, 2023
Padova (Italy), 27 July 2023 – A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA, aims to reduce mortality…
Read More
🇬🇧 Penta unveils Brighter Future Award 2023: Recognising innovators and visionaries driving positive change
15 Jun, 2023
Padua, Italy, 15 June 2023 – Penta, an international independent scientific network dedicated to maternal and child health research, is proud to unveil the Brighter Future Award (BFA), an annual…
Read More
🇬🇧 Global study highlights deaths from neonatal sepsis and steps to improve treatment
08 Jun, 2023
Geneva, 8 June 2023 – A global observational study, which involved more than 3,200 newborn babies suffering from sepsis in 19 hospitals in 11 countries, has shown that many newborns…
Read More🇮🇹 Sepsi nei neonati: ancora alta la mortalità nel mondo. Nuovi strumenti per facilitare diagnosi e cura
08 Jun, 2023
Studio internazionale condotto da Global Antibiotic Research and Development Partnership (GARDP) e Penta – Child Health Research. Coinvolti 19 ospedali di 11 Paesi, l’Ospedale Pediatrico Bambino Gesù per l’Europa. La…
Read More
🇮🇹 Nuovo finanziamento dall’Unione Europa all’Università di Padova e Penta per la ricerca su mpox e nuove epidemie
03 Apr, 2023
Il Consorzio VERDI, coordinato dal Dipartimento di Salute della Donna e del Bambino (SDB) dell’Università di Padova e dalla Fondazione Penta ETS, ha ricevuto dall’Unione Europea un importante finanziamento di 5…
Read More🇬🇧 EU tasks VERDI Consortium with investigating mpox and improving pandemic preparedness
30 Mar, 2023
The VERDI Consortium, coordinated by the University of Padua and Fondazione Penta ETS (Italy), has received an additional €5 million funding from the European Union (EU). Thanks to this contribution,…
Read More
🇬🇧 Experts call for urgent action to develop antibiotics for newborns
07 Dec, 2022
Padua (Italy), 7 December 2022 – Leading public health experts from around the globe are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly…
Read More
🇮🇹 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni
30 Jun, 2022
Padova, 30 giugno 2022 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni. Lo dimostra un ampio studio appena pubblicato…
Read More🇬🇧 Study reveals moderate effectiveness of Pfizer Covid-19 vaccine against Omicron in children aged 5-11
30 Jun, 2022
Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study…
Read More
🇬🇧 GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections
26 Apr, 2022
Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of…
Read More🇮🇹 Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci
26 Apr, 2022
Ginevra, 26 Aprile 2022 – Un importante studio sui neonati ha rivelato l’impatto della resistenza agli antibiotici sulla sepsi neonatale, una delle principali cause di morte tra i neonati. Al…
Read More
🇬🇧 European RBDCOV project to study HIPRA’s COVID-19 vaccine in children adolescents and immunocompromised patients
15 Feb, 2022
Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein. …
Read More
🇬🇧 Easy-to-take medicine better at suppressing HIV in children
30 Dec, 2021
UCL press release A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global…
Read More
🇬🇧 NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis
27 Nov, 2021
The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under…
Read More
🇬🇧 VERDI project launches
15 Nov, 2021
Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI, a new European research…
Read More
🇬🇧 New data on the duration of immune protection against SARS-CoV- 2 in children
02 Jul, 2021
A study published in the Pediatrics journal shows that children with mild forms of COVID-19 develop a greater and longer lasting antibody response than that of adults. The study involved 57…
Read More
🇮🇹 Nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini
28 Jun, 2021
Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni…
Read More
🇮🇹 NeoIPC: strategie di prevenzione e di controllo delle infezioni neonatali
15 Jun, 2021
Parte da Padova il progetto europeo NeoIPC, che mira a ridurre le infezioni e la trasmissione di batteri resistenti nelle unità di terapia intensiva neonatale. Padova, 15 giugno 2021 –…
Read More